14:00 - 15:00
ET
Webcast
What We Know (and Still Don’t Know) About Genes and Blood Cancer
We know more than ever about how blood cancers develop and respond to treatment. Genetic testing gives doctors better insight into what’s going on and guide treatment decision. Still, many big questions remain, including how to spot cancers earlier and who might be at higher risk.
Join us for a webcast where we unpack what we know, what we don’t and what’s coming next in genetic research.
We’ll cover:
- Risk and relapse: what genes can (and can’t) predict
- Why most blood cancers aren’t inherited
- How genetic testing guides diagnosis and treatment
- What new approaches could mean for earlier detection
This webcast is led by Dr. Florian Kuchenbauer, a clinician-scientist at Vancouver General Hospital.
Dr. Florian Kuchenbauer
Dr. Florian Kuchenbauer is a clinician-scientist at Vancouver General Hospital who specializes in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). His research focuses on the genetic drivers of these diseases and turning new scientific discoveries into improved patient care through strong translational and clinical trial work.